AI assistant
RESMED INC — Director's Dealing 2017
Dec 18, 2017
30071_dirs_2017-12-18_3d9a76ed-e935-46f9-ab28-f549a9da68d3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2017-11-10
Reporting Person: Sodhi Rajwant (President, SaaS Business)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-11-10 | ResMed Common Stock | F | 955 | $83.06 | Disposed | 29205 | Direct |
| 2017-11-10 | ResMed Common Stock | F | 1704 | $83.06 | Disposed | 27501 | Direct |
| 2017-11-10 | ResMed Common Stock | F | 1893 | $83.06 | Disposed | 25608 | Direct |
| 2017-11-10 | ResMed Common Stock | F | 518 | $83.06 | Disposed | 25090 | Direct |
Footnotes
F1: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/19/2014.
F2: Includes 152 shares of ResMed stock purchased on October 31, 2017, through the ResMed Employee Stock Purchase Plan.
F3: Corrects misstatement of shares reported. Certified outstanding shares totaled 6,528 for grant issued 11/19/2015 prior 16-b officer status.
F4: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/19/2015.
F5: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/16/2016.
F6: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 12/16/2013.
F7: Amendment adjusts for netted shares using the correct tax rate.